These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4226049)

  • 1. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical considerations on the use of a new preparation with hepatoprotective action].
    Di Lorenzo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experimentation with a new pharmacologic combination having a liver protective and detoxicant scope].
    Rossini A; Merlini R
    Minerva Med; 1967 Apr; 58(34 Suppl):1613-7. PubMed ID: 4226048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical observations on the therapeutic efficiency of the combination: arginine HCl, citrulline, ornithine HCl, vitamin B-12, folic acid and nicotinamide in liver diseases and in anemic deficiency syndromes].
    Drago U; Finotto E; Ongaro G
    Minerva Med; 1967 Apr; 58(34 Suppl):1592-6. PubMed ID: 4226044
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of vitamins and amino acids in the therapy of chronic liver diseases. Clinical results].
    Miracco A; Orlando V
    Minerva Med; 1967 Apr; 58(34 Suppl):1620-6. PubMed ID: 4226050
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-metabolic observations on the use in therapy of a combination of vitamin B-12, folic acid, nicotinamide and amino acids of the arginine group in patients with chronic liver diseases].
    Piro E; Nicoletti A; Ruffolo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1629-33. PubMed ID: 4226052
    [No Abstract]   [Full Text] [Related]  

  • 7. [On a combination of amino acids and vitamins in the treatment of liver diseases].
    Bazzicalupo G; Pietranera P
    Minerva Med; 1967 Apr; 58(34 Suppl):1587-92. PubMed ID: 4226043
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the therapeutic value of some amino acids in combination with vitamin B 12, folic acid and nicotinamide in the therapy of hepatic insufficiency].
    Meneghini P; Avanzi G
    Minerva Med; 1967 Apr; 58(34 Suppl):1596-603. PubMed ID: 4226045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experimentation with a new preparation: Polilevo].
    Floris E; Mura B
    Minerva Med; 1967 Apr; 58(34 Suppl):1633-4. PubMed ID: 4226053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the behavior of the bromophthalein test in a group of patients affected by the hepatitis virus, treated with a combination of some amino acids, nicotinamide, folic acid and vitamin B-12].
    Rizzo F
    Minerva Med; 1967 Apr; 58(34 Suppl):1603-5. PubMed ID: 4226046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-experimental findings on the use of a new liver protective agent].
    Catalfamo G; Melotti G; Soffritti E
    Minerva Med; 1967 Apr; 58(34 Suppl):1605-12. PubMed ID: 4226047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the therapeutic possibilities offered by the combination: substrates of the Krebs-Henseleit cycle and vitamins in hepatic toxicoses].
    Gai V; Gastaldi L; Nattero G
    Minerva Med; 1967 Apr; 58(34 Suppl):1585-6. PubMed ID: 4226042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on a new preparation with hepatoprotective action].
    Fanelli V
    Clin Ter; 1967 Jan; 40(2):145-56. PubMed ID: 4234340
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new hepatoprotective preparation. Biochemical aspects and clinical studies].
    Boselli A
    Clin Ter; 1968 Jan; 44(2):115-56. PubMed ID: 4244601
    [No Abstract]   [Full Text] [Related]  

  • 15. [The hepato-protective effect of a combination of amino acids of the Krebs-Henseleit cycle. Clinical and statistical considerations].
    Ruberti A; Mirizio A; Accardo G
    Clin Ter; 1969 Sep; 50(5):397-425. PubMed ID: 5382524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the hepatoprotective effect of 1-amino acids involved in the Krebs-Henseleit cycle associated with vitamins].
    Rossi L; Laghi V; Cavallaro A
    Minerva Med; 1968 Sep; 59(75):3919-30. PubMed ID: 4234452
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a new preparation with liver-protective and anti-anemic action].
    Cairella M
    Clin Ter; 1966 Dec; 39(6):567-76. PubMed ID: 4232883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of liver diseases with Hepatofalk].
    Hirsch W; Smerlings H
    Ther Ggw; 1976 Oct; 115(10):1719-54. PubMed ID: 136762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of a new drug association with a base of nucleosides in therapy of some liver diseases].
    De Martiis M
    Clin Ter; 1966 Aug; 38(4):331-41. PubMed ID: 4229942
    [No Abstract]   [Full Text] [Related]  

  • 20. A proposito di terapia epatotropa.
    Di Blasi S; Pintacuda S; Di Blasi G
    Minerva Med; 1968 Mar; 59(19):1034-41. PubMed ID: 4230815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.